Clonal heterogeneity in differentiation potential of immortalized human mesenchymal stem cells

被引:234
作者
Okamoto, T
Aoyama, T
Nakayama, T
Nakamata, T
Hosaka, T
Nishijo, K
Nakamura, T
Kiyono, T
Toguchida, J
机构
[1] Kyoto Univ, Inst Frontier Med Sci, Dept Tissue Regenerat, Sakyo Ku, Kyoto 6068057, Japan
[2] Kyoto Univ, Grad Sch Med, Dept Orthoped Surg, Sakyo Ku, Kyoto 6068057, Japan
[3] Aichi Canc Ctr, Res Inst, Div Virol, Chigusa Ku, Nagoya, Aichi 4648681, Japan
关键词
mesenchymal stem cell; telomerase; immortalization; HPV16E6; HPV16E7; Rb; p16; differentiation;
D O I
10.1016/S0006-291X(02)00661-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mesenchymal stem cells (MSCs) are bone marrow stroma-derived cells, which can differentiate into several types of mesenchymal tissues. Although regarded as tissue-specific stem cells, human MSCs (hMSCs) have a low proliferative ability with a finite life span, which is a hurdle to further analysis of their biology. Here we attempted to establish immortalized hMSCs by retrovirus-mediated gene transfer. The gain in telomerase activity obtained on expression of human telomerase reverse transcriptase (hTERT) was found not to be enough to make the cell line immortal. A combination of hTERT with human papillomavirus E6 and E7 successfully immortalized hMSCs without affecting the potential for adipogenic, osteogenic, and chondrogenic differentiation. From the parental immortalized hMSC, 100 single-cell derived clones were established, of which the differentiation properties varied considerably, including tri-, bi-, and uni-directional clones, suggesting that hMSCs are constituted by a group of cells with different differentiation potential. These cell lines, being the first established immortalized clonal cell lines of hMSCs, could provide insights into the mechanisms regulating the early steps of differentiation from undifferentiated MSCs into a specific lineage. (C) 2002 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:354 / 361
页数:8
相关论文
共 40 条
  • [1] Update on hepatic stem cells
    Alison, MR
    Poulsom, R
    Forbes, SJ
    [J]. LIVER, 2001, 21 (06): : 367 - 373
  • [2] Autologous mesenchymal stem cell-mediated repair of tendon
    Awad, HA
    Butler, DL
    Boivin, GP
    Smith, FNL
    Malaviya, P
    Huibregtse, B
    Caplan, AI
    [J]. TISSUE ENGINEERING, 1999, 5 (03): : 267 - 277
  • [3] Extension of life-span by introduction of telomerase into normal human cells
    Bodnar, AG
    Ouellette, M
    Frolkis, M
    Holt, SE
    Chiu, CP
    Morin, GB
    Harley, CB
    Shay, JW
    Lichtsteiner, S
    Wright, WE
    [J]. SCIENCE, 1998, 279 (5349) : 349 - 352
  • [4] Boyer SN, 1996, CANCER RES, V56, P4620
  • [5] Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO
  • [6] 2-F
  • [7] The biology of replicative senescence
    Campisi, J
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 (05) : 703 - 709
  • [8] MESENCHYMAL STEM-CELLS
    CAPLAN, AI
    [J]. JOURNAL OF ORTHOPAEDIC RESEARCH, 1991, 9 (05) : 641 - 650
  • [9] Mesenchymal stem cells: building blocks for molecular medicine in the 21st century
    Caplan, AI
    Bruder, SP
    [J]. TRENDS IN MOLECULAR MEDICINE, 2001, 7 (06) : 259 - 264
  • [10] Conget PA, 1999, J CELL PHYSIOL, V181, P67, DOI 10.1002/(SICI)1097-4652(199910)181:1<67::AID-JCP7>3.0.CO